Mayne Pharma confirms over half a billion successful institutional placement, shares surged 28%
Mayne Pharma shares surged 28% yesterday after the company confirmed it had raised over half a billion in an institutional placement at $1.50 a share and rights issue as part of its dramatic move into the competitive US generic drugs market.
Read More